11% to 12% interim absolute efficacy and 18% Euphrates....efficacy on undisclosed group needs to be shared.
The comapany has close to $10 MILL in their kitty-kat lil buddy.
The idea of floating "financing chit chat" would seem contrived "Beech Boy Material"
The company hasn't even met with the FDA yet.
While "less educated" shareholders bleed in the street, Josher decides to "chat up financing talk"
You smell like a paid troll Josher
Too bad..such a nice fellow... "sincerely apologizing" to other alias handles and stuff
You're a funny lil focker
Sqr